Synopsys Expected to Report Lower Q2 Earnings as Analysts Adjust Forecasts Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Nvidia Earnings in Focus Chipmakers China Commentary and Geopolitical Tensions Loom Over Market Intel Urges PC Makers to Adopt Latest Chips Amid AI Demand Potential Margin Catalyst Sojitz Eyes Growth in Australia and Uzbekistan with New Investment Strategy Telecoms CEO Warns Europe Underestimates Risks of US Dominance in Satellites and AI GCT Q1 2026 Earnings Strong EPS Beat Overshadows Stock Slight Decline Grindr Inc GRND Q4 2025 Earnings EPS Misses Estimates Stock Declines DIN Q1 2026 Earnings EPS Surpasses Estimates by 529 VerifyMe Q4 2025 Earnings EPS Misses Estimates as Revenue Details Remain Unavailable ENIC Q4 2025 Earnings Earnings Beat Estimates Amid Challenging Market Conditions FONR Q1 2025 Earnings Profitability Maintained Amid Limited Disclosure Flex Ltd FLEX Faces NearTerm Pressure as Shares Dip 239 to 13981 FB Financial Corporation FBK Holds Steady Near Midpoint as Trading Volume Remains Subdued Waters Corporation WAT Shows Modest Decline as Technical Levels Come into Focus Transdigm Group TDG Holds Near Support Resistance Tested in Recent Session Gorilla Technology Group Inc GRRR Capitalizes on Recent Momentum Approaches Key Resistance OpenAI Sets Sights on IPO as AI Competition Heats Up Confidential Filing Reportedly Imminent BCSF Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Edges Lower Muzero Acquisition Corp MUZE Holds Steady at 992 Amid Quiet Trading Indaptus Therapeutics INDP Surges 15 Biotech Stock Breaks Above Key Resistance Heritage Global Inc HGBL Stages a 4 Bounce Key Support Holds Amid LowVolume Recovery Shoulder Innovations Inc SI Consolidates Near Key Support Level After Flat Trading Day Cantor Equity Partners IV Inc CEPF Holds Steady at 1035 as Investors Await Catalyst Welltower Holds Nearly Flat Consolidating Near 216 Amid Sector Caution Crane Company CR Gains 15 as Shares Approach Key Resistance Levels Silexion Therapeutics SLXN Slips 3 as Shares Test Key Support at 040